Mahamaya Lifesciences Limited (BOM:544611)
166.50
-3.50 (-2.06%)
At close: May 25, 2026
43.53% (1Y)
| Market Cap | 3.90B |
| Revenue (ttm) | 3.30B +24.9% |
| Net Income | 165.23M +29.0% |
| EPS | 8.33 +10.4% |
| Shares Out | 23.41M |
| PE Ratio | 20.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,800 |
| Open | 170.15 |
| Previous Close | 170.00 |
| Day's Range | 166.00 - 170.15 |
| 52-Week Range | 111.00 - 205.05 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 25, 2026 |